Search research articles
Contact Us
Filters
Showing results (101-110 of 232) with videos related to
Page
of 24
Sort By:
Neuro-Oncology
|
January 1, 2020
Molecular subgrouping of atypical teratoid/rhabdoid tumors-a reinvestigation and current consensus
Ben Ho, Pascal D Johann, Yura Grabovska, et al.
Genes, Chromosomes & Cancer
|
April 25, 2021
Transposable element insertion as a mechanism of SMARCB1 inactivation in atypical teratoid/rhabdoid tumor
Christian Thomas, Kathrin Oehl-Huber, Susanne Bens, et al.
BMC Cancer
|
June 15, 2013
The histone deacetylase inhibitor SAHA acts in synergism with fenretinide and doxorubicin to control growth of rhabdoid tumor cells
Kornelius Kerl, David Ries, Rebecca Unland, et al.
Pediatric Blood & Cancer
|
June 8, 2021
Evidence for a low-penetrant extended phenotype of rhabdoid tumor predisposition syndrome type 1 from a kindred with gain of SMARCB1 exon 6
Uwe Kordes, Victor-Felix Mautner, Florian Oyen, et al.
Nature Communications
|
June 4, 2014
Identification of genes involved in the biology of atypical teratoid/rhabdoid tumours using Drosophila melanogaster
Astrid Jeibmann, Kristin Eikmeier, Anna Linge, et al.
Neuropathology and Applied Neurobiology
|
November 15, 2013
Loss of endoplasmic reticulum calcium pump expression in choroid plexus tumours
Lamia Ait-Ghezali, Atousa Arbabian, Astrid Jeibmann, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 21, 2024
Radiation Therapy Plays an Important Role in the Treatment of Atypical Teratoid/Rhabdoid Tumors: Analysis of the EU-RHAB Cohorts and Their Precursors
Sabine Frisch, Hanna Libuschewski, Sarah Peters, et al.
Neuro-Oncology
|
December 7, 2020
Corrigendum to: Molecular subgrouping of atypical teratoid/rhabdoid tumors-a reinvestigation and current consensus
Ben Ho, Pascal D Johann, Yura Grabovska, et al.
Clinical Nuclear Medicine
|
October 26, 2018
Characterization of Diffuse Gliomas With Histone H3-G34 Mutation by MRI and Dynamic 18F-FET PET
Franziska J Vettermann, Jörg Felsberg, Guido Reifenberger, et al.
Journal of Neuro-Oncology
|
January 22, 2017
SMAD dependent signaling plays a detrimental role in a fly model of SMARCB1-deficiency and the biology of atypical teratoid/rhabdoid tumors
Astrid Jeibmann, Jacqueline Schulz, Kristin Eikmeier, et al.
Page
of 24
Search research articles
Search
Showing results (101-110 of 232) with videos related to
Sort By:
Page
of 24
Neuro-Oncology
|
January 1, 2020
Molecular subgrouping of atypical teratoid/rhabdoid tumors-a reinvestigation and current consensus
Ben Ho, Pascal D Johann, Yura Grabovska, et al.
Genes, Chromosomes & Cancer
|
April 25, 2021
Transposable element insertion as a mechanism of SMARCB1 inactivation in atypical teratoid/rhabdoid tumor
Christian Thomas, Kathrin Oehl-Huber, Susanne Bens, et al.
BMC Cancer
|
June 15, 2013
The histone deacetylase inhibitor SAHA acts in synergism with fenretinide and doxorubicin to control growth of rhabdoid tumor cells
Kornelius Kerl, David Ries, Rebecca Unland, et al.
Pediatric Blood & Cancer
|
June 8, 2021
Evidence for a low-penetrant extended phenotype of rhabdoid tumor predisposition syndrome type 1 from a kindred with gain of SMARCB1 exon 6
Uwe Kordes, Victor-Felix Mautner, Florian Oyen, et al.
Nature Communications
|
June 4, 2014
Identification of genes involved in the biology of atypical teratoid/rhabdoid tumours using Drosophila melanogaster
Astrid Jeibmann, Kristin Eikmeier, Anna Linge, et al.
Neuropathology and Applied Neurobiology
|
November 15, 2013
Loss of endoplasmic reticulum calcium pump expression in choroid plexus tumours
Lamia Ait-Ghezali, Atousa Arbabian, Astrid Jeibmann, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 21, 2024
Radiation Therapy Plays an Important Role in the Treatment of Atypical Teratoid/Rhabdoid Tumors: Analysis of the EU-RHAB Cohorts and Their Precursors
Sabine Frisch, Hanna Libuschewski, Sarah Peters, et al.
Neuro-Oncology
|
December 7, 2020
Corrigendum to: Molecular subgrouping of atypical teratoid/rhabdoid tumors-a reinvestigation and current consensus
Ben Ho, Pascal D Johann, Yura Grabovska, et al.
Clinical Nuclear Medicine
|
October 26, 2018
Characterization of Diffuse Gliomas With Histone H3-G34 Mutation by MRI and Dynamic 18F-FET PET
Franziska J Vettermann, Jörg Felsberg, Guido Reifenberger, et al.
Journal of Neuro-Oncology
|
January 22, 2017
SMAD dependent signaling plays a detrimental role in a fly model of SMARCB1-deficiency and the biology of atypical teratoid/rhabdoid tumors
Astrid Jeibmann, Jacqueline Schulz, Kristin Eikmeier, et al.
Page
of 24